Characterization of Ly108 in the thymus: Evidence for distinct properties of a novel form of Ly108

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3031-3041

  Dutta, Mala ^a,b   Schwartzberg, Pamela L ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; ISOPROTEIN; PROTEIN KINASE FYN; PROTEIN LY108; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; HAPLOTYPE; LUPUS VULGARIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; THYMOCYTE; THYMUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, LY; CELL COMMUNICATION; CONSENSUS SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-FYN; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; THYMOCYTES; THYMUS GLAND;

EID: 84859393346     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103226     Document Type: Article

References (53)

1. Mavaddat, N., D. W. Mason, P. D. Atkinson, E. J. Evans, R. J. Gilbert, D. I. Stuart, J. A. Fennelly, A. N. Barclay, S. J. Davis, and M. H. Brown. 2000. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem. 275: 28100-28109.
2. Martin, M., X. Romero, M. A. de la Fuente, V. Tovar, N. Zapater, E. Esplugues, P. Pizcueta, J. Bosch, and P. Engel. 2001. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J. Immunol. 167: 3668-3676. (Pubitemid 32910809)
3. Flaig, R. M., S. Stark, and C. Watzl. 2004. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 172: 6524-6527. (Pubitemid 38669084)
4. Cao, E., U. A. Ramagopal, A. Fedorov, E. Fedorov, Q. Yan, J. W. Lary, J. L. Cole, S. G. Nathenson, and S. C. Almo. 2006. NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity 25: 559-570. (Pubitemid 44529046)
5. Falco, M., E. Marcenaro, E. Romeo, F. Bellora, D. Marras, F. Vély, G. Ferracci, L. Moretta, A. Moretta, and C. Bottino. 2004. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34: 1663-1672. (Pubitemid 39256048)
6. Punnonen, J., B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. de Vries. 1997. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185: 993-1004. (Pubitemid 27136792)
7. Romero, X., D. Benítez, S. March, R. Vilella, M. Miralpeix, and P. Engel. 2004. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens 64: 132-144. (Pubitemid 38969577)
8. Yan, Q., V. N. Malashkevich, A. Fedorov, E. Fedorov, E. Cao, J. W. Lary, J. L. Cole, S. G. Nathenson, and S. C. Almo. 2007. Structure of CD84 provides insight into SLAM family function. Proc. Natl. Acad. Sci. USA 104: 10583-10588. (Pubitemid 47185708)
9. Cannons, J. L., S. G. Tangye, and P. L. Schwartzberg. 2011. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29: 665-705.
10. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
11. Tsao, B. P., R. M. Cantor, K. C. Kalunian, C. J. Chen, H. Badsha, R. Singh, D. J. Wallace, R. C. Kitridou, S. L. Chen, N. Shen, et al. 1997. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 99: 725-731. (Pubitemid 27097675)
12. Fossati-Jimack, L., J. Cortes-Hernandez, P. J. Norsworthy, H. T. Cook, M. J. Walport, and M. Botto. 2008. Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice. Arthritis Rheum. 58: 2131-2141. (Pubitemid 351988105)
13. Wandstrat, A. E., C. Nguyen, N. Limaye, A. Y. Chan, S. Subramanian, X. H. Tian, Y. S. Yim, A. Pertsemlidis, H. R. Garner, Jr., L. Morel, and E. K. Wakeland. 2004. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21: 769-780. (Pubitemid 39626668)
14. Wang, A., F. Batteux, and E. K. Wakeland. 2010. The role of SLAM/CD2 polymorphisms in systemic autoimmunity. Curr. Opin. Immunol. 22: 706-714.
15. Zhong, M. C., and A. Veillette. 2008. Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity. J. Biol. Chem. 283: 19255-19264.
16. Keszei, M., C. Detre, S. T. Rietdijk, P. Muñoz, X. Romero, S. B. Berger, S. Calpe, G. Liao, W. Castro, A. Julien, et al. 2011. A novel isoform of the Ly108 gene ameliorates murine lupus. J. Exp. Med. 208: 811-822.
17. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462-469. (Pubitemid 28462434)
18. Shlapatska, L. M., S. V. Mikhalap, A. G. Berdova, O. M. Zelensky, T. J. Yun, K. E. Nichols, E. A. Clark, and S. P. Sidorenko. 2001. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166: 5480-5487. (Pubitemid 32374169)
19. Chan, B., A. Lanyi, H. K. Song, J. Griesbach, M. Simarro-Grande, F. Poy, D. Howie, J. Sumegi, C. Terhorst, and M. J. Eck. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5: 155-160. (Pubitemid 36204198)
20. Chen, R., S. Latour, X. Shi, and A. Veillette. 2006. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor. Mol. Cell. Biol. 26: 5559-5568. (Pubitemid 44134314)
21. Latour, S., G. Gish, C. D. Helgason, R. K. Humphries, T. Pawson, and A. Veillette. 2001. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2: 681-690. (Pubitemid 32747156)
22. Snow, A. L., R. A. Marsh, S. M. Krummey, P. Roehrs, L. R. Young, K. Zhang, J. van Hoff, D. Dhar, K. E. Nichols, A. H. Filipovich, et al. 2009. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 119: 2976-2989.
23. Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta, and A. Moretta. 2001. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194: 235-246. (Pubitemid 32730798)
24. Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J. Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346. (Pubitemid 30629159)
25. Castro, A. G., T. M. Hauser, B. G. Cocks, J. Abrams, S. Zurawski, T. Churakova, F. Zonin, D. Robinson, S. G. Tangye, G. Aversa, et al. 1999. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J. Immunol. 163: 5860-5870.
26. Li, C., C. Iosef, C. Y. Jia, V. K. Han, and S. S. Li. 2003. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J. Biol. Chem. 278: 3852-3859. (Pubitemid 36801114)
27. Coffey, A. J., R. A. Brooksbank, O. Brandau, T. Oohashi, G. R. Howell, J. M. Bye, A. P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20: 129-135. (Pubitemid 28455444)
28. Nichols, K. E., D. P. Harkin, S. Levitz, M. Krainer, K. A. Kolquist, C. Genovese, A. Bernard, M. Ferguson, L. Zuo, E. Snyder, et al. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 95: 13765-13770. (Pubitemid 28523047)
29. Bar, R. S., C. J. DeLor, K. P. Clausen, P. Hurtubise, W. Henle, and J. F. Hewetson. 1974. Fatal infectious mononucleosis in a family. N. Engl. J. Med. 290: 363-367.
30. Harada, S., K. Sakamoto, J. K. Seeley, T. Lindsten, T. Bechtold, J. Yetz, G. Rogers, G. Pearson, and D. T. Purtilo. 1982. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects. J. Immunol. 129: 2532-2535. (Pubitemid 13245517)
31. Provisor, A. J., J. J. Iacuone, R. R. Chilcote, R. G. Neiburger, and F. G. Crussi. 1975. Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. N. Engl. J. Med. 293: 62-65.
32. Purtilo, D. T., C. K. Cassel, J. P. Yang, and R. Harper. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1: 935-940.
33. Booth, C., K. C. Gilmour, P. Veys, A. R. Gennery, M. A. Slatter, H. Chapel, P. T. Heath, C. G. Steward, O. Smith, A. O'Meara, et al. 2011. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 117: 53-62.
34. Pachlopnik Schmid, J., D. Canioni, D. Moshous, F. Touzot, N. Mahlaoui, F. Hauck, H. Kanegane, E. Lopez-Granados, E. Mejstrikova, I. Pellier, et al. 2011. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 117: 1522-1529.
35. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282-287. (Pubitemid 36139134)
36. Qi, H., J. L. Cannons, F. Klauschen, P. L. Schwartzberg, and R. N. Germain. 2008. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455: 764-769.
37. Cannons, J. L., H. Qi, K. T. Lu, M. Dutta, J. Gomez-Rodriguez, J. Cheng, E. K. Wakeland, R. N. Germain, and P. L. Schwartzberg. 2010. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253-265.
38. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174: 3153-3157. (Pubitemid 40354014)
39. Pasquier, B., L. Yin, M. C. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701. (Pubitemid 40395115)
40. Ma, C. S., S. Pittaluga, D. T. Avery, N. J. Hare, I. Maric, A. D. Klion, K. E. Nichols, and S. G. Tangye. 2006. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J. Clin. Invest. 116: 322-333. (Pubitemid 43228349)
41. Ma, C. S., N. J. Hare, K. E. Nichols, L. Dupré, G. Andolfi, M. G. Roncarolo, S. Adelstein, P. D. Hodgkin, and S. G. Tangye. 2005. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J. Clin. Invest. 115: 1049-1059. (Pubitemid 40489410)
42. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345. (Pubitemid 40460564)
43. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762. (Pubitemid 350102258)
44. Czar, M. J., E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, and P. L. Schwartzberg. 2001. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98: 7449-7454. (Pubitemid 32567969)
45. Grusby, M. J., H. Auchincloss, Jr., R. Lee, R. S. Johnson, J. P. Spencer, M. Zijlstra, R. Jaenisch, V. E. Papaioannou, and L. H. Glimcher. 1993. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. USA 90: 3913-3917. (Pubitemid 23134136)
46. Cannons, J. L., L. J. Yu, B. Hill, L. A. Mijares, D. Dombroski, K. E. Nichols, A. Antonellis, G. A. Koretzky, K. Gardner, and P. L. Schwartzberg. 2004. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 21: 693-706. (Pubitemid 39489893)
47. van Oers, N. S., W. Tao, J. D. Watts, P. Johnson, R. Aebersold, and H. S. Teh. 1993. Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta. Mol. Cell. Biol. 13: 5771-5780. (Pubitemid 23260678)
48. Nakayama, T., A. Singer, E. D. Hsi, and L. E. Samelson. 1989. Intrathymic signalling in immature CD4+CD8+ thymocytes results in tyrosine phosphorylation of the T-cell receptor zeta chain. Nature 341: 651-654. (Pubitemid 19257315)
49. Li, S. C., G. Gish, D. Yang, A. J. Coffey, J. D. Forman-Kay, I. Ernberg, L. E. Kay, and T. Pawson. 1999. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Curr. Biol. 9: 1355-1362.
50. Poy, F., M. B. Yaffe, J. Sayos, K. Saxena, M. Morra, J. Sumegi, L. C. Cantley, C. Terhorst, and M. J. Eck. 1999. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell 4: 555-561. (Pubitemid 29531135)
51. Finerty, P. J., Jr., R. Muhandiram, and J. D. Forman-Kay. 2002. Side-chain dynamics of the SAP SH2 domain correlate with a binding hot spot and a region with conformational plasticity. J. Mol. Biol. 322: 605-620.
52. Hwang, P. M., C. Li, M. Morra, J. Lillywhite, D. R. Muhandiram, F. Gertler, C. Terhorst, L. E. Kay, T. Pawson, J. D. Forman-Kay, and S. C. Li. 2002. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome. EMBO J. 21: 314-323. (Pubitemid 34137293)
53. Bida, A. T., J. L. Upshaw Neff, C. J. Dick, R. A. Schoon, A. Brickshawana, C. C. Chini, and D. D. Billadeau. 2011. 2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis. Mol. Immunol. 48: 1149-1159.